Thursday, December 25, 2014 4:33:49 AM
Perhaps the CEO has potential acquisition, merger or revenue share interest partners he's been speaking with and without the CB out of the way, there isn't a solid way of knowing what type of share base he has to work with in terms of valuation and new share issuance...
Perhaps the CEO's other business has enabled him to experience a bit of work in hostile environments rife with insurgent groups, criminal elements and tribal warlords and sometimes the best strategy is allowing ones enemy to expend their ammunition and ordnance on small advance forward operators while observing from the high ground with far greater firepower...
Or perhaps any type of positive announcements made while the CB is still out there could be misconstrued as being aligned with said CB holders hence the accusations made about 'pump and dump'. Even worse would be if a new one was issued while positive developments are being announced thereby subjecting investors to the same thing that happened on the previous CEO's watch...
Whatever the case, time will be the telling factor as positive announcements are only the beginning not the end game result. Execution is, and that takes much longer due to integration and expansion.
In terms of the 13G or 13D filings, I wouldn't put much thought into it with the CB guys or Knight Capital Group because the only objective for both is 'trading profits' and arbitrage between sale price and conversion price.
Haven't heard back from them yet and will update all when I do. They are very responsive and will let me know shortly.
best
Recent LGIQ News
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 02:43:28 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/09/2024 09:08:29 PM
- Form SC 13D - General statement of acquisition of beneficial ownership • Edgar (US Regulatory) • 11/13/2023 09:30:22 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/03/2023 08:11:35 PM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 10/25/2023 09:04:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/25/2023 09:03:09 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 10/10/2023 10:48:27 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/02/2023 04:28:19 PM
- Form PREM14A - Preliminary proxy statements relating to merger or acquisition • Edgar (US Regulatory) • 09/29/2023 09:20:23 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/08/2023 08:32:45 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/01/2023 05:05:22 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/14/2023 08:57:03 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/25/2023 01:51:06 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM